The estimated Synkrino Biotherapeutics valuation is $1.2M. This Synkrino Biotherapeutics valuation is an independent model output, not a verified appraisal, official mark, or financial advice. Founders: David Ott net worth and Jason Barbour net worth.
Search this company in the directory
The estimated Synkrino Biotherapeutics valuation is $1.2M. This Synkrino Biotherapeutics valuation is an independent model output, not a verified appraisal, official mark, or financial advice.
Synkrino Biotherapeutics raised $120K in disclosed funding. How much Synkrino Biotherapeutics raised informs the estimated Synkrino Biotherapeutics valuation on this hub. Independent estimate only — not a complete financing history or financial advice.
David Ott and Jason Barbour founded Synkrino Biotherapeutics. Estimated net worth for each founder is on the linked profile. Figures are independent model estimates, not verified net worth.